{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T20:19:32Z","timestamp":1770063572371,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"DOI":"10.7759\/cureus.39228","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T17:12:17Z","timestamp":1684516337000},"source":"Crossref","is-referenced-by-count":1,"title":["Gemcitabine-Induced Radiation Recall Phenomenon in Cervical Cancer: A Case Report"],"prefix":"10.7759","author":[{"given":"Jesus Paula","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela A","family":"Velho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filomena M","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103527","article-title":"Radiation recall reactions: an oncologic enigma","volume":"168","author":"McKay MJ","year":"2021","unstructured":"McKay MJ, Foster R. Radiation recall reactions: an oncologic enigma. Crit Rev Oncol Hematol. 2021, 168:103527. 10.1016\/j.critrevonc.2021.103527","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000181590.85476.e3","article-title":"Gemcitabine-related radiation recall in a patient with pancreatic cancer","volume":"17","author":"Saif MW","year":"2006","unstructured":"Saif MW, Sellers S, Russo S. Gemcitabine-related radiation recall in a patient with pancreatic cancer. Anticancer Drugs. 2006, 17:107-11. 10.1097\/01.cad.0000181590.85476.e3","journal-title":"Anticancer Drugs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21499","article-title":"Breast radiation recall phenomenon after Astra-Zeneca COVID-19 vaccine: a case series","volume":"14","author":"Marples R","year":"2022","unstructured":"Marples R, Douglas C, Xavier J, Collins AJ. Breast radiation recall phenomenon after Astra-Zeneca COVID-19 vaccine: a case series. Cureus. 2022, 14:e21499. 10.7759\/cureus.21499","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15548","article-title":"Radiation recall dermatitis in patients treated with immune checkpoint inhibitors: a case report and literature review","volume":"13","author":"Yigit E","year":"2021","unstructured":"Yigit E, Guven DC, Aksoy S, Yazici G. Radiation recall dermatitis in patients treated with immune checkpoint inhibitors: a case report and literature review. Cureus. 2021, 13:e15548. 10.7759\/cureus.15548","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199409000-00015","article-title":"Advances in the chemotherapy of gynecologic cancer","volume":"6","author":"Neijt JP","year":"1994","unstructured":"Neijt JP. Advances in the chemotherapy of gynecologic cancer. Curr Opin Oncol. 1994, 6:531-8. 10.1097\/00001622-199409000-00015","journal-title":"Curr Opin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7314\/apjcp.2013.14.9.5385","article-title":"Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer","volume":"14","author":"Hashemi FA","year":"2013","unstructured":"Hashemi FA, Akbari EH, Kalaghchi B, Esmati E. Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer. Asian Pac J Cancer Prev. 2013, 14:5385-9. 10.7314\/apjcp.2013.14.9.5385","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1517\/14728214.2015.1002768","article-title":"Emerging drugs for the treatment of cervical cancer","volume":"20","author":"Serrano-Olvera A","year":"2015","unstructured":"Serrano-Olvera A, Cetina L, Coronel J, Due\u00f1as-Gonz\u00e1lez A. Emerging drugs for the treatment of cervical cancer. Expert Opin Emerg Drugs. 2015, 20:165-82. 10.1517\/14728214.2015.1002768","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7150\/jca.40276","article-title":"Tolerability, efficacy and feasibility of concurrent gemcitabine and cisplatin (CGP) combined with intensity modulated radiotherapy for loco-regionally advanced carcinoma of the cervix","volume":"11","author":"Drokow EK","year":"2020","unstructured":"Drokow EK, Zi L, Qian H, et al.. Tolerability, efficacy and feasibility of concurrent gemcitabine and cisplatin (CGP) combined with intensity modulated radiotherapy for loco-regionally advanced carcinoma of the cervix. J Cancer. 2020, 11:2632-8. 10.7150\/jca.40276","journal-title":"J Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2022.04.001","article-title":"Radiation recall dermatitis: a review of the literature","volume":"49","author":"Bhangoo RS","year":"2022","unstructured":"Bhangoo RS, Cheng TW, Petersen MM, et al.. Radiation recall dermatitis: a review of the literature. Semin Oncol. 2022, 49:152-9. 10.1053\/j.seminoncol.2022.04.001","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0090-8258(03)00404-9","article-title":"Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy","volume":"91","author":"Schwartz BM","year":"2003","unstructured":"Schwartz BM, Khuntia D, Kennedy AW, Markman M. Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy. Gynecol Oncol. 2003, 91:421-2. 10.1016\/s0090-8258(03)00404-9","journal-title":"Gynecol Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0000000000003024","article-title":"Radiation recall myositis detected with 18F-FDG PET\/CT after a treatment of cervical cancer","volume":"45","author":"Lemay J","year":"2020","unstructured":"Lemay J, Bouchard M, Rousseau \u00c9. Radiation recall myositis detected with 18F-FDG PET\/CT after a treatment of cervical cancer. Clin Nucl Med. 2020, 45:e336-8. 10.1097\/RLU.0000000000003024","journal-title":"Clin Nucl Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2302\/kjm.2014-0015-CR","article-title":"A case of severe rectal hemorrhage possibly caused by radiation recall after administration of gemcitabine","volume":"65","author":"Nishimoto K","year":"2016","unstructured":"Nishimoto K, Akise Y, Miyazawa M, Kutsuki S, Hashimoto S, Uchida A. A case of severe rectal hemorrhage possibly caused by radiation recall after administration of gemcitabine. Keio J Med. 2016, 65:16-20. 10.2302\/kjm.2014-0015-CR","journal-title":"Keio J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.9663","article-title":"Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix","volume":"29","author":"Due\u00f1as-Gonz\u00e1lez A","year":"2011","unstructured":"Due\u00f1as-Gonz\u00e1lez A, Zarb\u00e1 JJ, Patel F, et al.. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011, 29:1678-85. 10.1200\/JCO.2009.25.9663","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00674","article-title":"Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial","volume":"37","author":"da Costa SC","year":"2019","unstructured":"da Costa SC, Bonadio RC, Gabrielli FC, et al.. Neoadjuvant chemotherapy with cisplatin and gemcitabine followed by chemoradiation versus chemoradiation for locally advanced cervical cancer: a randomized phase II trial. J Clin Oncol. 2019, 37:3124-31. 10.1200\/JCO.19.00674","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0000000000000067","article-title":"Laparoscopic extrafascial hysterectomy (completion surgery) after primary chemoradiation in patients with locally advanced cervical cancer: technical aspects and operative outcomes","volume":"24","author":"Favero G","year":"2014","unstructured":"Favero G, Pierobon J, Genta ML, et al.. Laparoscopic extrafascial hysterectomy (completion surgery) after primary chemoradiation in patients with locally advanced cervical cancer: technical aspects and operative outcomes. Int J Gynecol Cancer. 2014, 24:608-14. 10.1097\/IGC.0000000000000067","journal-title":"Int J Gynecol Cancer"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-02971-5","article-title":"Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort","volume":"21","author":"Van Damme A","year":"2023","unstructured":"Van Damme A, Rombaut J, Makar A, et al.. Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic results of a unique tertiary care single-center retrospective cohort. World J Surg Oncol. 2023, 21:84. 10.1186\/s12957-023-02971-5","journal-title":"World J Surg Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01096","article-title":"Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: results from the embrace-I study","volume":"41","author":"Schmid MP","year":"2023","unstructured":"Schmid MP, Lindegaard JC, Mahantshetty U, et al.. Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: results from the embrace-I study. J Clin Oncol. 2023, 41:1933-42. 10.1200\/JCO.22.01096","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/151382-gemcitabine-induced-radiation-recall-phenomenon-in-cervical-cancer-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:40Z","timestamp":1707508900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/151382-gemcitabine-induced-radiation-recall-phenomenon-in-cervical-cancer-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.39228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,19]]}}}